-transparent.png){kind=logo}
The neuroprotective effect of vinconate, a novel vinca alkaloid derivative, was examined in a rat model of forebrain ischemia induced by 4-vessel occlusion. Hippocampal cell loss was quantified histologically 3 days after 10 or 15 min of ischemia. Intraperitoneal application of vinconate (25 and 50 mg/kg) 10 min before and immediately after 10 min of ischemia significantly reduced the neuronal cell loss in the CA1 sector of the hippocampus. Protective effect of vinconate against 15 min of ischemia was reduced, but there was still significant protection at the higher dose. Autoradiography using 14C-vinconate showed that the drug easily penetrates the blood-brain barrier and distributes in the hippocampus. The result suggests that vinconate prevents ischemic neuronal damage by direct action on the hippocampal CA1 neurons.
T Araki, and
K Nishioka, and
S Yuki, and
K Kogure
December 1992,
European journal of pharmacology,
T Araki, and
K Nishioka, and
S Yuki, and
K Kogure
January 1988,
Life sciences,
T Araki, and
K Nishioka, and
S Yuki, and
K Kogure
January 1988,
Acta neuropathologica,
T Araki, and
K Nishioka, and
S Yuki, and
K Kogure
December 1986,
No to shinkei = Brain and nerve,
T Araki, and
K Nishioka, and
S Yuki, and
K Kogure
August 1997,
Neurological research,
T Araki, and
K Nishioka, and
S Yuki, and
K Kogure
September 1997,
Nature medicine,
T Araki, and
K Nishioka, and
S Yuki, and
K Kogure
June 1999,
European journal of pharmacology,
T Araki, and
K Nishioka, and
S Yuki, and
K Kogure
January 1993,
Brain research,
T Araki, and
K Nishioka, and
S Yuki, and
K Kogure
July 1992,
Brain research,
T Araki, and
K Nishioka, and
S Yuki, and
K Kogure
May 2005,
Neurobiology of aging,
